Answers are grounded in this paper and cite their sources.
Evidence for increased tumor incidence in NKG2D-deficient mice has set NKG2D as the first innate immune receptor implicated in immunosurveillance of tumors. In this viewpoint article, we discuss recent genetic insight into NKG2D-mediated suppression of spontaneous tumor development in the context of NKG2D signaling properties. Moreover, we identify unresolved issues and consider how an understanding of NKG2D-receptor and -ligand biology can facilitate successful therapeutic intervention of human cancer.
No takes yet. Share an insight, caveat, or question.
Bryceson et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: